ALZN
Alzamend Neuro, Inc.
Alzamend Neuro, Inc. insider trading
Insiders at Alzamend Neuro, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Ault Milton C III (Director) buying $108.9K of ALZN, filed Aug 31, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $221.9K
- Sold
- $3.1K
- Insiders
- 1
- Latest trade
- Apr 14, 2026
From SEC filings · last 30 days
Recent ALZN insider transactions
Ault Milton C IIIDirector
Bought 108,388 sh at $1.00 · Apr 14, 2026
$108.9K
FilingAult Milton C IIIDirector
Bought 108,388 sh at $1.00 · Apr 14, 2026
$108.9K
FilingAult Milton C IIIDirector
Sold 2,000 sh at $1.56 · Aug 26, 2026
−$3.1K
FilingAult Milton C IIIDirector
Bought 2,000 sh at $1.03 · Apr 14, 2026
$2.1K
FilingAult Milton C IIIDirector
Bought 2,000 sh at $1.03 · Apr 14, 2026
$2.1K
Filing
SEC Form 4 data, Q3 2024 to Q2 2026
ALZN insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 4 insiders traded ALZN on the open market: 10 purchases worth $134.6K and 27 sales worth $2.2M. In the last four quarters alone: 1 purchase ($108.4K) and 25 sales ($2.2M), by 3 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$108.4K1 buy | — | |
| Q1 2026 | — | — | |
| Q4 2025 | — | −$946.2K10 sales | |
| Q3 2025 | — | −$1.3M15 sales | |
| Q2 2025 | — | −$6.2K2 sales | |
| Q1 2025 | +$25.9K7 buys | — | |
| Q4 2024 | — | — | |
| Q3 2024 | +$3002 buys | — |
- Largest purchase
- +$108.4K of ALZN by Ault Milton C III (Director) on Apr 14, 2026.
- Largest sale
- −$247.4K of ALZN by Ault Milton C III (Director) on Oct 08, 2025.
Open-market transactions through Jun 30, 2026most recent first
Ault Milton C III
Director
+$108.4K
Apr 14, 2026
108,388 sh · $1.00
Ault Milton C III
Director
−$3.8K
Dec 23, 2025
1,851 sh · $2.07
Horne William B.
Director
−$7.1K
Dec 19, 2025
3,333 sh · $2.12
McGrath Lynne Fahey
Director
−$69
Oct 23, 2025
30 sh · $2.29
Ault Milton C III
Director
−$47.3K
Oct 09, 2025
20,397 sh · $2.32
Ault Milton C III
Director
−$247.4K
Oct 08, 2025
101,394 sh · $2.44
Ault Milton C III
Director
−$142.9K
Oct 07, 2025
57,379 sh · $2.49
Ault Milton C III
Director
−$201K
Oct 06, 2025
82,033 sh · $2.45
Ault Milton C III
Director
−$160.8K
Oct 03, 2025
65,903 sh · $2.44
Ault Milton C III
Director
−$49.4K
Oct 02, 2025
20,686 sh · $2.39
Ault Milton C III
Director
−$86.4K
Oct 01, 2025
36,777 sh · $2.35
Ault Milton C III
Director · 10% Owner
−$8.3K
Sep 30, 2025
3,566 sh · $2.33
Ault Milton C III
Director · 10% Owner
−$88.5K
Sep 29, 2025
38,324 sh · $2.31
Ault Milton C III
Director · 10% Owner
−$87.2K
Sep 26, 2025
37,738 sh · $2.31
Ault Milton C III
Director · 10% Owner
−$33.8K
Sep 25, 2025
14,628 sh · $2.31
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Apr 14, 2026 | Ault Milton C IIIDirector | 108,388 | $1.00 | +$108.4K |
| Dec 23, 2025 | Ault Milton C IIIDirector | 1,851 | $2.07 | −$3.8K |
| Dec 19, 2025 | Horne William B.Director | 3,333 | $2.12 | −$7.1K |
| Oct 23, 2025 | McGrath Lynne FaheyDirector | 30 | $2.29 | −$69 |
| Oct 09, 2025 | Ault Milton C IIIDirector | 20,397 | $2.32 | −$47.3K |
| Oct 08, 2025 | Ault Milton C IIIDirector | 101,394 | $2.44 | −$247.4K |
| Oct 07, 2025 | Ault Milton C IIIDirector | 57,379 | $2.49 | −$142.9K |
| Oct 06, 2025 | Ault Milton C IIIDirector | 82,033 | $2.45 | −$201K |
| Oct 03, 2025 | Ault Milton C IIIDirector | 65,903 | $2.44 | −$160.8K |
| Oct 02, 2025 | Ault Milton C IIIDirector | 20,686 | $2.39 | −$49.4K |
| Oct 01, 2025 | Ault Milton C IIIDirector | 36,777 | $2.35 | −$86.4K |
| Sep 30, 2025 | Ault Milton C IIIDirector · 10% Owner | 3,566 | $2.33 | −$8.3K |
| Sep 29, 2025 | Ault Milton C IIIDirector · 10% Owner | 38,324 | $2.31 | −$88.5K |
| Sep 26, 2025 | Ault Milton C IIIDirector · 10% Owner | 37,738 | $2.31 | −$87.2K |
| Sep 25, 2025 | Ault Milton C IIIDirector · 10% Owner | 14,628 | $2.31 | −$33.8K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check ALZN — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Alzamend Neuro, Inc. is outside the ~660 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are ALZN insiders buying or selling?
- Between Apr 14, 2026 and Apr 14, 2026, 1 Alzamend Neuro, Inc. insider made 4 open-market purchases worth $221.9K and 1 sale worth $3.1K, a net purchase of $218.8K.
- How much ALZN stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 4 Alzamend Neuro, Inc. insiders made 10 open-market purchases worth $134.6K and 27 sales worth $2.2M. In the four quarters to Jun 30, 2026: 1 purchase ($108.4K) and 25 sales ($2.2M). The largest purchase was Ault Milton C III buying $108.4K on Apr 14, 2026. The largest sale was Ault Milton C III selling $247.4K on Oct 08, 2025.
- What was the largest recent ALZN insider trade?
- Ault Milton C III (Director) bought $108.9K of ALZN stock on Apr 14, 2026 at about $1.00 a share.
- When did an insider last buy ALZN shares?
- The most recent open-market purchase on file is Ault Milton C III (Director) buying $108.9K on Apr 14, 2026.
- Where does ALZN insider trading data come from?
- From the Form 4 filings Alzamend Neuro, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
The week's real signals — open-market insider buys, cluster formations and what insiders did in ALZN and across the market — in plain English, with grants and routine vesting stripped out. Free, and honest about what the data can and cannot say.